This initiative will provide a variety of tools to promote awareness and education, including some resources in both English and Spanish. Prevent Blindness has named the month of May as “Inherited ...
The Vision Simulator shows disease progression and vision loss simulations for diabetic macular edema, diabetic retinopathy, AMD, XLRP, and achromatopsia. It’s an old adage that knowledge is power, ...
Akari Therapeutics, Ocuphire Pharma, and PharmAbcine are among the companies that have shared their plans for presentations the ARVO annual conference, being held in Seattle, Washington. More ...
According to the company, SGT-1001 uses its novel gene coding technology for gene integration via transposition. It plans to advance SGT-1001 into the clinic in the first half of 2025. Preclinical ...
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11 [BYOOVIZ (ranibizumab)], and explore the practical implications of biosimilars in the broader ...
Rising costs of metabolic agents, particularly those used in the treatment of diabetes, impacts patients and the medical systems, such as Medicare and Medicaid. Published research from the University ...
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11 [BYOOVIZ (ranibizumab)], and explore the practical implications of biosimilars in the broader ...
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11 [BYOOVIZ (ranibizumab)], and explore the practical implications of biosimilars in the broader ...
The Intracortical Visual Prosthesis (ICVP), a wireless visual prosthesis brain implant, has achieved 2 years of successful testing after surgical implantation in a patient who is blind. The prosthesis ...
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11 [BYOOVIZ (ranibizumab)], and explore the practical implications of biosimilars in the broader ...
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11 [BYOOVIZ (ranibizumab)], and explore the practical implications of biosimilars in the broader ...
Expert retina specialists discuss the efficacy and safety data of the ranibizumab biosimilar, SB11 [BYOOVIZ (ranibizumab)], and explore the practical implications of biosimilars in the broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results